ValiRx's Cytolytix gets EU patent allowance for nanoparticles
(Alliance News) - ValiRx PLC on Monday said it has received a notice of allowance from the European Patent Office for "nanoparticle for anti-cancer peptides and uses thereof", a key patent application for majority-owned subsidiary Cytolytix Ltd. Read More